| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.094 | 0.006 |